Sep 17, 2025 Sep 17, 2025 Updated Sep 18, 2025 BELOIT — “Fifty years from now, this will be the isotope capital of the world,” said Greg Piefer, founder and CEO of SHINE Technologies. He joined ...

NorthStar Medical Radioisotopes, LLC (NorthStar), a leading radiopharmaceutical company, is proud to announce the formation of a multi-faceted strategic partnership with the University of Wisconsin ...

BELOIT — “Fifty years from now, this will be the isotope capital of the world,” said Gref Piefer, founder and CEO of SHINE Technologies. He joined NorthStar Medical Radioisotopes President and CEO ...

Actinium-225 is an alpha emitter, spewing out tiny bundles of energy that promise to kill cancer cells, but only at short range. This isotope and others like it are the focus of a ...

According to the World Nuclear Association, over 10,000 hospitals worldwide use radioisotopes in medicine1 with reports estimating that the nuclear radioisotope market will grow annually from $7 ...

Nuclear medicine techniques are becoming increasingly important not only for cancer care but also for diagnosing cardiac and neurological disorders ...

The Department of Energy's Oak Ridge National Laboratory is vital to a robust domestic isotope R&D and production ecosystem in the U.S. and is able to ...

Along with the development of 18F- and 68Ga-labeled PET agents, radioisotopes have enabled precise diagnostic imaging across diverse clinical applications. Similarly, radiotherapy, a long-established ...

A production delay at three European nuclear reactors will result in a shortage of radioisotopes crucial for the detection of disease in medical imaging. The shortage is expected to affect ...

NEW YORK and AUSTIN, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp.